Modified-release paracetamol-containing products to be suspended from EU market

December 15, 2017 – The CMDh has endorsed by majority a European Medicines Agency recommendation to suspend marketing of modified- or prolonged-release products containing paracetamol (designed to release paracetamol slowly over a longer period than the usual immediate-release products). The recommendation was made by the Agency’s experts in medicines safety, the Pharmacovigilance Risk Assessment Committee (PRAC). CMDh agreed with … (leggi tutto)